StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.48 on Friday. The firm has a market cap of $14.43 million, a P/E ratio […]
More Stories
Salesforce, Inc. (NYSE:CRM) Director G Mason Morfit Sells 15,353 Shares
Salesforce, Inc. (NYSE:CRM – Get Free Report) Director G Mason Morfit sold 15,353 shares of the company’s stock in a...
Midnight Sun Mining (CVE:MMA) Trading 51.3% Higher – Here’s Why
Midnight Sun Mining Corp. (CVE:MMA – Get Free Report) shares were up 51.3% during trading on Saturday . The company...
Intuit Inc. (NASDAQ:INTU) Insider Scott D. Cook Sells 73,655 Shares
Intuit Inc. (NASDAQ:INTU – Get Free Report) insider Scott D. Cook sold 73,655 shares of the stock in a transaction...
Hempalta (CVE:HEMP) Trading Down 20% – Here’s What Happened
Shares of Hempalta Corp. (CVE:HEMP – Get Free Report) traded down 20% on Saturday . The company traded as low...
KLA (NASDAQ:KLAC) Updates Q2 2025 Earnings Guidance
KLA (NASDAQ:KLAC – Get Free Report) updated its second quarter 2025 earnings guidance on Thursday. The company provided EPS guidance...
IntegraFin (LON:IHP) Shares Down 12.7% – Should You Sell?
IntegraFin Holdings plc (LON:IHP – Get Free Report) dropped 12.7% during trading on Thursday . The stock traded as low...